$PBIO Proteomics Several papers in 2019 reporte
Post# of 72699
(Total Views: 112)
Posted On: 01/15/2020 1:03:57 PM
$PBIO Proteomics
Several papers in 2019 reported on the use of PCT Platform for proteomic research. The proteome consists of all the proteins made or modified by an organism. Studies of proteins using PBI's high pressure PCT Platform included protein structure, drug delivery, and disease states. Such studies could eventually lead to the routine use of the PCT Platform in clinical diagnostics and precision medicine, a market that is expected to reach $217 billion by 2028 (BIS Research, 2019).
Mr. Richard T. Schumacher, President and CEO of PBI, said: "We are pleased that the number of PCT-related publications in 2019 exceeded 20 for the second year in a row. We are also pleased with the wide range of applications highlighted in the publications, as these applications fulfill needs in many large and growing markets. For example, it is estimated that by 2025, the combined projected market sizes for cancer research, biomarker discovery, and proteomics could be in excess of $200 billion (Zion Market Research, 2019). In addition, the food safety testing market is projected to grow to $24.6 billion by 2023 (MarketsandMarkets, January 2019)."
Mr. Schumacher concluded: "We believe that the credibility gained through scientific papers such as the more than 20 published in 2019, and the supportive data and new applications that the authors developed and presented in their publications, will enable PBI to better address a number of very large and growing markets, which we expect will result in increased sales of our PCT Systems going forward."
Several papers in 2019 reported on the use of PCT Platform for proteomic research. The proteome consists of all the proteins made or modified by an organism. Studies of proteins using PBI's high pressure PCT Platform included protein structure, drug delivery, and disease states. Such studies could eventually lead to the routine use of the PCT Platform in clinical diagnostics and precision medicine, a market that is expected to reach $217 billion by 2028 (BIS Research, 2019).
Mr. Richard T. Schumacher, President and CEO of PBI, said: "We are pleased that the number of PCT-related publications in 2019 exceeded 20 for the second year in a row. We are also pleased with the wide range of applications highlighted in the publications, as these applications fulfill needs in many large and growing markets. For example, it is estimated that by 2025, the combined projected market sizes for cancer research, biomarker discovery, and proteomics could be in excess of $200 billion (Zion Market Research, 2019). In addition, the food safety testing market is projected to grow to $24.6 billion by 2023 (MarketsandMarkets, January 2019)."
Mr. Schumacher concluded: "We believe that the credibility gained through scientific papers such as the more than 20 published in 2019, and the supportive data and new applications that the authors developed and presented in their publications, will enable PBI to better address a number of very large and growing markets, which we expect will result in increased sales of our PCT Systems going forward."
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!